title: Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
abstract: We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator shocks.
authors: UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, David Geffen School of Medicine at UCLA, A2-237 CHS, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1679, USA. JBradfield@mednet.ucla.edu
authors: Jason
authors: J
authors: Bradfield
authors: Roderick
authors: R
authors: Tung
authors: Noel G
authors: NG
authors: Boyle
authors: Kalyanam
authors: K
authors: Shivkumar
mesh_terms: D000208:Acute Disease; D002317:Cardiovascular Agents / Q000627:therapeutic use; D017115:Catheter Ablation; D002986:Clinical Trials as Topic; D017147:Defibrillators, Implantable / Q000009:adverse effects* / Q000592:standards; D004554:Electric Countershock / Q000009:adverse effects* / Q000295:instrumentation* / Q000379:methods; D004562:Electrocardiography; D019544:Equipment Failure Analysis; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D018579:Patient Selection; D012720:Severity of Illness Index; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology / Q000601:surgery; D017180:Tachycardia, Ventricular / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*
chemical_list: D002317:Cardiovascular Agents